ライフサイエンスコーパス: screening

1 he FCR Inventory (FCRI) severity subscale at screening.

2 us and applied the strain to high-throughput screening.

3 volcanii due to electrostatic screening.

4 ee survival according to disease duration at screening.

5 es, quality of life, mortality, and harms of screening.

6 emoglobin (Hb) are used in colorectal cancer screening.

7 risks of cancer and the importance of cancer screening.

8 es or those that have had different types of screening.

9 nd 0.45% (P = .17), respectively, at initial screening.

10 86% sensitivity when compared to qPCR-based screening.

11 screening and 181 articles during full-text screening.

12 set a timeline for implementing lung cancer screening.

13 the synthesis without the need for extensive screening.

14 y end point was patient participation in CRC screening 1 year after the intervention.

15 This concept was further explored by screening 42 targets from Mycobacterium tuberculosis.

16 G+ relatives diagnosed with HCM after family screening, 74 FG+/phenotype-negative relatives, and 9 wi

17 Screening a collection of clinical EPEC isolates reveale

18 onger activity than other anti-gp120 MAbs in screening against one of two gp120s and against DS-SOSIP

19 f affected FDRs, we used the Microsimulation Screening Analysis model to estimate costs and effects o

20 ded 4,332 articles during title and abstract screening and 181 articles during full-text screening.

21 tion of screening at age 40 years, 5-year re-screening and 3-year surveillance intervals (unless shor

22 Nutrition screening and assessment are infrequently performed in p

23 e citations were screened, 32 underwent full screening and data extraction, and 14 trials were eligib

24 wever, due to poor access and affordability, screening and diagnosis for ID is often limited to proxy

25 lyses, and systematic reviews that addressed screening and diagnostic and treatment approaches for OC

26 Measurement of high-attenuation areas by screening and diagnostic computed tomography may be warr

27 aches, and assess utility and limitations in screening and early tier assessments.

28 visually, beginning with an initial clinical screening and followed potentially by dermoscopic analys

29 rough a combination of rigorous experimental screening and in silico virtual screening, we recently i

30 A focused screening and lead optimization effort identified 4b (GS

31 onsiderable variation in multiple aspects of screening and management of the disease.

32 ttention in efforts to improve pretransplant screening and management protocols before and after tran

33 efore enable simultaneous transcriptome-wide screening and mechanistic investigation at large scales.

34 can 216Dx is a reasonable approach for urine screening and might produce negative results in as few a

35 presence of early occult disease and/or the screening and monitoring of indolent lymphoma in individ

36 a systematic and efficient way to implement screening and monitoring of modifiable risks in the clin

37 ter efforts in prevention, as well as better screening and more effective and affordable treatment.

38 plant skin cancer is fundamental to targeted screening and prevention in this population.

39 Randomisation was done via a central patient screening and randomisation system with an interactive (

40 e validity of using pretreatment Periodontal Screening and Recording (PSR) index sextant scores to es

41 nd more modest reductions in cervical cancer screening and sexual risk behaviors.

42 The conventional hybridoma screening and subcloning process is generally considered

43 h KHK were discovered through fragment-based screening and subsequent optimization using structure-ba

44 The Hill coefficient in the screening and the shape of the dimerization curve in sma

45 estimate benefits and harms of preeclampsia screening and the test performance of different screenin

46 Screening and timely treatment at quarterly vs biannual

47 These cells permit sensitive, large-scale screening and titration of infectious virus in experimen

48 ncluding emergent magnetic monopoles, charge screening and transport, as well as magnonic response.

49 factors, symptoms, and suggested options for screening and treatment are given.

50 is needed to understand the effectiveness of screening and treatment for celiac disease, accuracy of

51 its and harms associated with thyroid cancer screening and treatment of early thyroid cancer in asymp

52 016-20 to 2036-40) who have a combination of screening and vaccination history, and weighted to estim

53 s were found in 18 (7.6%) of 237 patients at screening, and there was a clear age gradient.

54 te miRNAs were identified during the initial screening, and we subsequently validated upregulation of

55 discuss the potential of a non-directed mass-screening approach for mAb production against some glyca

56 In conclusion, the new PSI-HR-MS/MS screening approach was suitable for comprehensive urine

57 eptor for PGE2-G, we performed a subtractive screening approach where mRNA from PGE2-G response-posit

58 eening and the test performance of different screening approaches over the course of pregnancy was li

59 e to numerous enzymes and to engineering and screening approaches to identify activators and blockers

60 Using systematic and unbiased functional screening approaches, we discovered that the Id family o

61 e bounded as small to none, and the harms of screening are minimal.

62 rate that antigens identified by serological screening are targets of multifunctional cellular immune

63 ucible inhibitory effects within the primary screening assay.

64 g high throughput ToxCast data from in vitro screening assays and predictive pathway models, high-thr

65 activation capacity and optimized for simple screening assays with luciferase or fluorescent reporter

66 o failure to meet inclusion criteria (87% of screening assessments) rather than meeting specific excl

67 meeting specific exclusion criteria (52% of screening assessments).

68 plant recipients with CF should initiate CRC screening at age 30 years within 2 years of the transpla

69 he preferred screening method, initiation of screening at age 40 years, 5-year re-screening and 3-yea

70 o the intricate interplay between the charge screening at the PZT/SNNO interface and the charge trans

71 mense potential for fast and high-throughput screening bacterial chemotaxis.

72 compounds, and a comparison of a nontargeted screening based both on the study of the most discrimina

73 f HRMS signals, a comparison of the targeted screening based on more than 100 compounds, and a compar

74 We found no difference in uptake of screening between the active choice and control groups (

75 rst time to compare the D816V status of the "screening blood sample" used to guide BM biopsy in suspe

76 Of these, 92% tested D816V-positive in the screening blood sample.

77 proaches have also been taken, which rely on screening broad, natural genetic diversity for metabolic

78 ed by researchers and regulators in a hazard screening capacity to assess the potential of a protein

79 direct evidence on the benefits or harms of screening children and adolescents for excess weight.

80 The model is helpful in screening children with high risk of developing obesity.

81 Suspect screening compared masses with those of previously repor

82 es and false negatives under high-throughput screening conditions is particularly difficult.

83 After conducting a compound screening contest in 2014, we report results acquired fr

84 we applied the correction to HX-MS excipient screening data collected for a pharmaceutically relevant

85 y available, high-quality DNA, RNA, and drug screening data.

86 dependently conducted abstract and full-text screenings, data extractions, and risk of bias (ROB) ass

87 screening methodology, related to robustness screening described by Glorius et al., builds a broad un

88 ether the rates and tumor characteristics of screening-detected and interval cancers differ for two-d

89 Results Breast cancer was screening-detected in 16 women (age range, 33-58 years).

90 eneric reminders about regional rates of CRC screening did not increase screening rates compared with

91 ty attributes, optimizing manufacturing, and screening drugs/biomaterials.

92 -based eligibility would improve lung cancer screening efficacy.

93 own ocular disease who desires a routine eye screening examination is eligible.

94 e is adequate evidence to bound the harms of screening for and treatment of preeclampsia as no greate

95 Selective use of screening for CAC might be considered in individuals wit

96 Screening for cancer in patients with unprovoked venous

97 review the evidence on benefits and harms of screening for celiac disease in asymptomatic adults, ado

98 aly, were randomly assigned to be invited to screening for colorectal cancer with FS or CT colonograp

99 aria compared to algorithms that incorporate screening for danger signs.

100 rvices Task Force (USPSTF) recommendation on screening for gynecologic conditions with pelvic examina

101 In screening for host factors that interact with HIV-1 MA,

102 metabolism, can be detected through newborn screening for hyperphenylalaninemia (HPA).

103 tified Arabidopsis pex6 and pex26 mutants by screening for inefficient seedling beta-oxidation phenot

104 valuated by clinical examination and genomic screening for mutations in SCN9A and SCN11A.

105 ompted primary care providers to perform HCV screening for patients seen in primary care clinic (1) b

106 The USPSTF recommends screening for preeclampsia in pregnant women with blood

107 The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening redu

108 In screening for proteins that interact with ASK1 in the co

109 ase in the percentage of patients undergoing screening for T2D (89 of 283 [31.4%] vs 26 of 282 [9.2%]

110 ith PLA2R1-associated MN, and more intensive screening for the presence of malignancies may be warran

111 tients with IA supports the need for routine screening for this sensitivity as a cause of anaphylaxis

112 rs, presentation, optimal management of, and screening for urologic malignancies in kidney transplant

113 jected it to random mutagenesis, followed by screening for variants whose in vivo folding displays in

114 dy, we demonstrate the utility of "admixture screening" for the discovery of new multicomponent heter

115 (IVIVE) analyses translating high-throughput screening (HTS) data to human relevance have been limite

116 In this study, we utilized high-throughput screening (HTS) in vitro data of PAHs to predict health

117 Protein expression screening identified an inverse correlation between Daam

118 High-throughput screening identified anthracyclines including doxorubici

119 apse video imaging compiled from the optical screening images revealed unexpected differences in grow

120 he findings lend support to consideration of screening imaging of the brain for patients with HER2-po

121 his microfluidic device will facilitate drug screening in a relevant microenvironment thanks to its s

122 Heart Association (ACC/AHA) recommend lipid screening in all adults older than 20 years to identify

123 However, the efficacy of this screening in families not selected by autopsy has never

124 Fragment-based screening in human cells thus provides an extensive prot

125 to emphasize sun protection and skin cancer screening in individuals who tan indoors.

126 hese two orthogonal markers for liver cancer screening in patients with high-risk cirrhosis generates

127 We aim to investigate the value of clinical screening in relatives of all subjects who died suddenly

128 the proportion of women who participated in screening in the study groups.

129 nefit, and there is no evidence to recommend screening in this group.

130 d screening measurements like "hidden-target screening" in complex environmental matrices (such as wa

131 e), and thus was used in genetic testing for screening individuals at high risk.

132 tic assays for interaction analysis and drug screening involving membrane components.

133 Adding surveillance to FIT screening is not cost-effective based on the Dutch ICER

134 trained vs untrained PCPs are needed before screening is widely implemented in large health care sys

135 pite early detection during routine clinical screening, is associated with substantial short- and lon

136 ion scales (Test of Infant Motor Performance Screening Items [TIMPSI], The Children's Hospital of Phi

137 ential is an electric potential in the Debye screening layer of an electrolyte, which represents a ke

138 Screening led by either specialists or ICU teams was equ

139 ional and nationwide projections useful as a screening-level assessment of climate impacts on CyanoHA

140 Even low charge screening lifts the phonon Kohn anomaly near the K point

141 Patients underwent a screening lower-extremity duplex ultrasound approximatel

142 d a platform for microfluidics-assisted cell screening (MACS) that overcomes this trade-off by tempor

143 The patient reported normal findings at screening mammography and colonoscopy.

144 d longitudinal outcomes, with mean change in screening mammography use of +2.6% (range, -33.2% to +42

145 This information was used for compound screening measurements like "hidden-target screening" in

146 non-invasive, inexpensive, easily accessible screening method could be useful in both clinical and re

147 copy could offer a rapid and high-throughput screening method for identification of Leptospermum hone

148 d be used in a manner similar to the testing/screening method for neural tube defects and common chro

149 ed for large-scale use, this high-throughput screening method will facilitate rapid screening of nano

150 We recommend colonoscopy as the preferred screening method, initiation of screening at age 40 year

151 luate the effectiveness of this quantitative screening method.

152 A general screening methodology, related to robustness screening d

153 ectiveness of 2 population-based skin cancer screening methods and to assess their budget effect and

154 nsity of the pre-frying oil are suggested as screening methods for estimating the MCPD-E and G-E cont

155 positioning stage for automated high-content screening microscopy and provide detailed step-by-step i

156 of individuals and could supplement current screening modalities to aid early diagnosis of high-risk

157 herapeutics have been impeded by the lack of screening models that faithfully replicate prion disease

158 2120 women were recruited and underwent 3861 screening MR imaging studies, covering an observation pe

159 Novel activities can be discovered by screening natural Bt isolates or through modifications o

160 By screening naturally occurring, polymorphic, non-human pr

161 Neither meeting criteria for screening nor history of receptive anal sex was signific

162 H3K27me3 site in EED discovered by in-house screening, Novartis scientists have now produced a compo

163 ells into haemogenic endothelium followed by screening of 26 candidate haematopoietic stem-cell-speci

164 Finally, virtual screening of 29332 metabolites predicted 146 competitive

165 Screening of a 50000-member library of natural and synth

166 mine if the intervention was associated with screening of a demographically higher-risk population th

167 Initial screening of a series of over 50 newly characterized 2-a

168 Phytochemical compound screening of all Fagioli di Sarconi beans performed by f

169 rgence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasibl

170 Screening of all publically available V. cholerae genome

171 means of its attenuation and new targets for screening of antiviral drugs.

172 Screening of bacterial colonies to identify new biocatal

173 Our screening of bat samples collected in Kenya from 2007 to

174 BB) models are crucial tools to enable rapid screening of brain-penetrating drugs.

175 ectroscopy has the potential to enable rapid screening of cancers and impact next-generation cancer d

176 In the largest screening of CD in the United States to date outside of

177 Routine screening of children with suspected ZIKV infection for

178 es the density functional theory (DFT) based screening of chiral ligands for transition-metal-catalyz

179 pproach was suitable for comprehensive urine screening of different drug classes and might be a promi

180 PCR screening of ETEC isolates revealed that 8.6% (n = 13) o

181 ystem is also being used for high-throughput screening of genes, gene regulatory regions, and long no

182 h the graphene polarization charge and ionic screening of ions adsorbed on the graphene as well as ch

183 Exosome based screening of key HPVOPC associated molecules could be be

184 le rounds of affinity maturation through the screening of macrocyclic peptide libraries produced in E

185 ability of the developed zebrafish model for screening of molecules with therapeutic value against th

186 The ranking and screening of MOS sensors, specific for volatile organic

187 say that enables the relatively fast kinetic screening of multiple compounds.

188 Here, we deployed genome-scale CRISPR-Cas9 screening of MYCN-amplified neuroblastoma and found a pr

189 noassays and was applied in this work to the screening of mycotoxins.

190 ghput screening method will facilitate rapid screening of nanomaterial toxicity and thus inform the r

191 cterial and host factors and high throughput screening of novel therapeutics becoming the mainstay of

192 By automation-assisted screening of numerous sediment samples, we detected Nean

193 We build the case for universal screening of private well water quality around arsenic,

194 well suited for multiplexed single-molecule screening of protein libraries, and should enable the in

195 lysts for this reaction was initiated by the screening of simple binary and ternary admixtures of Pd/

196 Advances in the synthesis and screening of small-molecule libraries have accelerated t

197 265 papers were chosen for closer screening of the abstracts and 93 for full text evaluati

198 High-throughput screening of the host transcriptional response to variou

199 SIL following implementation of universal AC screening offered to all HIV-infected women.

200 study analyzed the impact of first-trimester screening on the spectrum of congenital heart defects (C

201 nophil count (>/=150 per cubic millimeter at screening or >/=300 per cubic millimeter during the prev

202 If implemented as either a population-level screening or clinical diagnostic tool, we believe this p

203 ges with established implications for cancer screening or prevention.

204 t CE spectral mammography and MR imaging for screening or staging from 2010 through 2014 were include

205 ent neutralization activity based on initial screening or to evaluate neutralization magnitude-breadt

206 Here, through a biochemical and structural screening paradigm, we have identified JNJ0966, a highly

207 To evaluate the feasibility of screening patients at risk of lung carcinoma via analysi

208 Biochemical markers can also help in screening patients for the presence of small fibre neuro

209 xamination, it is unclear whether performing screening pelvic examinations in asymptomatic women has

210 had at least one of the following within the screening period of 4 weeks: platelet transfusion, sympt

211 easy, rapid and cost-effective point-of-need screening phenols in smoked food samples.

212 the spectral properties of the eye-colouring screening pigments are discussed within the context of t

213 To address this need, we have developed a screening platform that enables accurate quantification

214 L) human cell lines and a custom CRISPR/Cas9 screening platform, we identify the H3K9 methyltransfera

215 and feasibility of implementing lung cancer screening policies based on risk prediction models shoul

216 tion between implementation of state newborn screening policies for critical congenital heart disease

217 to develop a convenient assay for accurately screening populations and to use this assay to determine

218 opy referral rates in the first round of HPV screening, possibly dampened by HPV vaccine effect; in t

219 etecting environmental EDC contamination and screening potential NHR-targeted pharmaceuticals.

220 Screening, preventive therapy, and surveillance for tube

221 Our search and study screening process adhered to the PRISMA Guidelines.

222 The national information system of the CRC screening program kept track of the number of invitation

223 INTERPRETATION: Systematic, community-based screening programme of fracture risk in older women in t

224 ent to support the implementation of T cruzi screening programmes at primary health centres in Europe

225 Attempts to control this epidemic with screening programs and antibiotic therapy have failed.

226 hically higher-risk population than previous screening programs and if melanoma incidence and thickne

227 High-throughput methods for screening protein-protein interactions enable the rapid

228 We propose an ophthalmic screening protocol to diagnose retinitis in pediatric HS

229 To describe a skin cancer screening quality initiative in a large health care syst

230 population Considerations: Studies show that screening rates among children vary by race/ethnicity an

231 onal rates of CRC screening did not increase screening rates compared with usual care.

232 cord-based prompt on hepatitis C virus (HCV) screening rates in baby boomers in primary care and acce

233 Additional studies comparing screening rates, specialty referrals, and patient outcom

234 of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLC

235 l methods for the purpose of high-throughput screening remains very limited.

236 owards addressing these issues by increasing screening resolution and analyzing the effects of off ta

237 nal biopsies following initial and secondary screening, respectively.

238 red in the early differential diagnosis when screening results are positive for HPA.

239 Surprisingly, genetic screening reveals that yeast FTase can modify sequences

240 fectiveness of colonoscopy surveillance in a screening setting.

241 Persons without prior screening should be considered for screening up to age 8

242 Prospective studies evaluating cancer screening strategies in adults with unprovoked VTE that

243 nd harms (e.g., overdiagnosis) of risk-based screening strategies using these models.

244 to estimate costs and effects of colonoscopy screening strategies with different age ranges and inter

245 actors, and the effect of different types of screening strategies.

246 g tests in asymptomatic persons, and optimal screening strategies.

247 Here, we develop a screening strategy for modulators of ATP-PRT and identif

248 A global peptide library-based screening strategy revealed that the proteasomes have ov

249 or prospective cohort studies that evaluated screening, studies evaluating test accuracy, RCTs of tre

250 ve Orbitrap were compared by retrospectively screening surface water samples for 95 pharmaceuticals.

251 s into apoE biology and establishes a robust screening system to monitor apoE conformation.

252 and the lack of rapid, sensitive biological screening systems.

253 By screening TAK1-associated signaling pathways with inhibi

254 e diagnostic potential of this approach as a screening technique for non-Hodgkin lymphoma and melanom

255 Based on standard screening techniques, sickle retinopathy reportedly occu

256 Currently, there is a lack of in vivo screening technologies for the discovery of compounds th

257 A sectors approach shows good screening test characteristics for the detection of CSME

258 In only four years, this screening test has revolutionized prenatal care globally

259 and recommends specific strategies based on screening test implementation.

260 en (mean [SD] age, 39.8 [12.5] years) with a screening test were recorded between 2008 and 2012, and

261 enable for biomarker identification and drug-screening testing and led to the identification of the E

262 We examined colorectal cancer screening tests according to quartiles of risk of mortal

263 nd treatment for celiac disease, accuracy of screening tests in asymptomatic persons, and optimal scr

264 By screening the NIH clinical collections of FDA-approved d

265 After screening through Lipinski's rule of five filter for ora

266 ble new approaches to prevent CDI, including screening to identify and isolate carriers, universal gl

267 study, we performed a novel drug-repurposing screening to identify Food and Drug Administration-appro

268 e study, we used comparative flow cytometric screening to identify ICAM-1 as a potential target for m

269 onsider point-of-care CRP-based tuberculosis screening to improve the efficiency of intensified case

270 gene cluster predictions and 'essential gene screening' to provide an interactive page for rapid iden

271 and fast, the method can serve as a primary screening tool for TMJ pathology, before proceeding to c

272 nscription, thus making it an efficient drug screening tool that can be used for therapeutic interven

273 ical characteristics to be employed as a pre-screening tool, when combined with other data such as pa

274 s been proposed for several years as a rapid screening tool, whereby negative specimens are excluded

275 ngs also support the use of neuropathic pain screening tools in these patients and treatment algorith

276 invasive and therefore unsuitable for use as screening tools, but a non-invasive, inexpensive, easily

277 Screening tools, such as the DN4 questionnaire, and trea

278 as well as the lack of large-scale neonatal screening tools.

279 s, thus limiting their use as rapid clinical screening tools.

280 ostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found no reduction.

281 Positive screening triggered confirmatory specialist bedside swal

282 or greater and less than 170 mm Hg at second screening underwent renal angiography and were randomly

283 out prior screening should be considered for screening up to age 85, depending on age and comorbiditi

284 f differences and changes in vaccination and screening uptake by ethnicity in England, over time.

285 onducted a randomized controlled trial of AF screening using an AliveCor Kardia monitor attached to a

286 this study were identified through a virtual screening using HIV-reverse transcriptase (RT), adenylat

287 mug/kg, and exceeded the human health cancer screening value of 12 mug/kg in 48% of the national samp

288 y of Life Single-Item Scale were measured at screening, visit 6, and visit 9.

289 We performed screening visual fields using a calibrated iPad 2 with t

290 in using structural information for virtual screening (VS) of libraries and for structure-based drug

291 e identified by this competitive engraftment screening was cardiotrophin-1, a member of the interleuk

292 By cDNA library screening, we identified an immune cell-specific, co-sti

293 experimental screening and in silico virtual screening, we recently identified novel classes of EPIs

294 tenofovir disoproxil fumarate regimen before screening were included in primary efficacy analyses.

295 isk for retinoblastoma require more frequent screening, which may preferentially be examinations unde

296 The widespread use of mammographic screening will increase the number of patients diagnosed

297 a-like symptoms, determine the usefulness of screening with computed tomography coronary angiography

298 esting strategy, routine universal anorectal screening with respect to chlamydia and gonorrhea preval

299 rticipation (ie, attendance at breast cancer screening) within 90 days of the date of the first offer

300 Kinome-wide screening would have the advantage of providing structur